![Sanofi and MannKind announce global licensing agreement for Afrezza® (insulin human) rapid-acting inhaled insulin - Drug Target Review Sanofi and MannKind announce global licensing agreement for Afrezza® (insulin human) rapid-acting inhaled insulin - Drug Target Review](http://www.drugtargetreview.com/wp-content/uploads/T1D-diabetes-fund.jpg)
Sanofi and MannKind announce global licensing agreement for Afrezza® (insulin human) rapid-acting inhaled insulin - Drug Target Review
![FDA approves first Glucose Monitoring System without fingersticks by Abbott Laboratories; Sanofi and Innovation Health announce a digital therapeutics pilot program for Type 2 diabetics | by The Health Prospect Global | Medium FDA approves first Glucose Monitoring System without fingersticks by Abbott Laboratories; Sanofi and Innovation Health announce a digital therapeutics pilot program for Type 2 diabetics | by The Health Prospect Global | Medium](https://miro.medium.com/v2/resize:fit:1000/1*wVs311xTZSGM2cOOt7u3kQ.jpeg)
FDA approves first Glucose Monitoring System without fingersticks by Abbott Laboratories; Sanofi and Innovation Health announce a digital therapeutics pilot program for Type 2 diabetics | by The Health Prospect Global | Medium
![5 children Type 1 Diabetes, Coeliacs, me and my husband: Sanofi Officially Launches It's New Blood Glucose Meter 5 children Type 1 Diabetes, Coeliacs, me and my husband: Sanofi Officially Launches It's New Blood Glucose Meter](http://2.bp.blogspot.com/-ZNliE5pty2g/T13P-D4LLQI/AAAAAAAAAZM/tQOtO6rYj4s/s1600/iBG8.jpg)